Onyx Seeks Suitors After Rejecting Amgen’s Bid

July 1 (Bloomberg) -- Onyx Pharmaceuticals, the maker of the cancer drug Nexavar, said it is in contact with other possible acquirers after rejecting an unsolicited $120-a-share cash takeover bid from Amgen Onyx shares surged. Dominic Chu reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Amazon's Presence at the Oscars
10:16 - Hollywood's biggest weekend is just around the corner with the 89th annual Academy Awards on Sunday. We see some familiar names like Meryl Streep and Ryan Gosling, but there is one new player grabbing attention. Bloomberg's Kaitlin Meehan reports on “Bloomberg Technology.” (Source: Bloomberg)
  • The Self-Driving Car Fight Between Google and Uber
  • Lucid Motors Aims to Rival Tesla
  • Personal Capital CEO Says Banks Need to Change Attitude